Funding
Series B · Healthtech

Faro AI raises $37.3m Series B for clinical-development agents

The round supports expansion of AI-agent capabilities for pharmaceutical trial operations.

Updated Oct 16, 2026By RoundOS Funding desk

Faro AI raised $37.3 million in Series B financing on August 30 to expand AI-agent capabilities for clinical development. The company builds structured data infrastructure and tools for pharmaceutical trial operations.

Funding history

Series B · This round$37.3M

Sources

  1. Faro AI Raises $37.3M for AI Agents in Clinical Trialsaibusinessweekly.net · Aug 30, 2026
  2. startupdb.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026
CureBay

CureBay operates a hybrid healthcare network for rural and underserved communities in India.

~₹1BPre-Series C · Oct 22, 2026
iCUREX

Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.

¥140MSeries A first close: equity and debt · Oct 22, 2026

Related